Work to lower drug costs and prevent price gouging.

Val T. Hoyle · Oregon · Democratic

policy impact 0.80 specificity 0.73 extraction confidence 95%

Contest this claim

Occurrences

Standing up to big pharma to bring down drug costs, and going after anyone who tries to price gouge Oregonians.

Commits to reducing prescription drug costs and targeting price gouging.

Priorities | Val Hoyle for Congress
campaign · campaign_site · model gpt-5.4-mini

Evidence

"We need to lower the cost of prescription drugs, hold big corporations accountable for price-gouging..." The page also says Hoyle introduced the Affordable Pricing for Taxpayer-Funded Prescription Drugs Act, which "would lower prescription drug prices by preventing pharmaceutical companies from price-gouging Americans on drugs that are developed with taxpayer money."

Official issue-page language shows Hoyle still publicly identifies lowering prescription drug costs and preventing price gouging as an active priority in her current office, but it does not show new legislative or administrative success during the lookback window.

unresolved same_term

Health | Congresswoman Val Hoyle
secondary · model gpt-5.4-mini · confidence 84%

Contest this evidence item

Hoyle announced legislation to combat price gouging on taxpayer-funded prescription drugs, saying the bill would require affordable pricing agreements before granting exclusive rights to develop prescription drugs or other healthcare products.

This is the clearest official evidence of concrete action behind the promise: Hoyle introduced a bill targeting prescription drug price gouging. But the bill page shows only introduction and referral, not enactment or later legislative progress.

partial same_term A for effort

Representatives Hoyle and Doggett Introduce Legislation to Lower Prescription Drug Pricing | Congresswoman Val Hoyle
secondary · model gpt-5.4-mini · confidence 91%

Contest this evidence item

Assessments

never same_term A for effort

Hoyle made a concrete same-term legislative effort by introducing H.R. 3093, the Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023, aimed at lowering prescription drug prices and preventing price gouging for taxpayer-funded drugs. However, the bill remained at the introduction/referral stage in the 118th Congress and did not become law, and the evidence does not show another enacted federal outcome attributable to Hoyle that delivered the promised result. Because there was a serious legislative attempt but no fulfilled policy outcome, this should be scored as not delivered with an effort badge.

provider codex_cli · model gpt-5.5 · confidence 90%